Safety and efficacy of eblasakimab, an IL-13R alpha 1 monoclonal antibody, in adults with moderate-to-severe atopic dermatitis: a phase 1b, multiple-ascending dose study. Supplementary information

Safety and efficacy of eblasakimab, an IL-13R alpha 1 monoclonal antibody, in adults with moderate-to-severe atopic dermatitis: a phase 1b, multiple-ascending dose study. Supplementary information

This dataset contains figures, tables, and documents referenced in: Safety and efficacy of eblasakimab, an IL-13R alpha 1 monoclonal antibody, in adults with moderate-to-severe atopic dermatitis: a phase 1b, multiple-ascending dose study. (Blauvelt et al.)

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Baker, Stuart
Format: Dataset
Sprache:eng
Schlagworte:
Dermatology
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This dataset contains figures, tables, and documents referenced in: Safety and efficacy of eblasakimab, an IL-13R alpha 1 monoclonal antibody, in adults with moderate-to-severe atopic dermatitis: a phase 1b, multiple-ascending dose study. (Blauvelt et al.)
DOI:10.17632/g6m6884znc